{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:51:17Z","timestamp":1792003877929,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jacep.2025.03.013","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:10:13Z","timestamp":1747231813000},"page":"1708-1717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes and Burdens to Return-to-Play for Phenotype Negative Athletes With a Genetic Heart Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Katherine A.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Martijn","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Tobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jacep.2025.03.013_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2021.04.026","article-title":"Return-to-play for athletes with long QT syndrome or genetic heart diseases predisposing to sudden death","volume":"78","author":"Tobert","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacep.2025.03.013_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2023.05.059","article-title":"Return-to-play for elite athletes with genetic heart diseases predisposing to sudden cardiac death","volume":"82","author":"Martinez","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacep.2025.03.013_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jamacardio.2023.1042","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"8","author":"Lampert","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"37","key":"10.1016\/j.jacep.2025.03.013_bib4","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies. Developed by the Task Force on the Management of Cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jacep.2025.03.013_bib5","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jacep.2025.03.013_bib6","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jacep.2025.03.013_bib7","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Writing Committee Members","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"10.1016\/j.jacep.2025.03.013_bib8","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacep.2025.03.013_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jacep.2025.03.013_bib10","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.jacc.2020.08.044","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary. A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacep.2025.03.013_bib11","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.106.624502","article-title":"Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice","volume":"114","author":"Kirchhof","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacep.2025.03.013_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/eurheartj\/ehab772","article-title":"Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study","volume":"43","author":"Cerrone","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacep.2025.03.013_bib13","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/hmg\/ddt508","article-title":"Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model","volume":"23","author":"Lyon","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.jacep.2025.03.013_bib14","doi-asserted-by":"crossref","first-page":"H174","DOI":"10.1152\/ajpheart.00295.2015","article-title":"Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt\/beta-catenin signaling","volume":"310","author":"Martherus","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.jacep.2025.03.013_bib15","article-title":"Heart rate recovery after exercise is associated with arrhythmic events in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Lieve","year":"2020","journal-title":"Circ-Arrhythmia Elec"},{"issue":"3","key":"10.1016\/j.jacep.2025.03.013_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.hrthm.2017.10.008","article-title":"Accentuated vagal antagonism paradoxically increases ryanodine receptor calcium leak in long-term exercised Calsequestrin2 knockout mice","volume":"15","author":"Ho","year":"2018","journal-title":"Heart Rhythm"},{"issue":"14","key":"10.1016\/j.jacep.2025.03.013_bib17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"27","key":"10.1016\/j.jacep.2025.03.013_bib18","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/eurheartj\/ehv110","article-title":"Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Ruwald","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2025.03.013_bib19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijcard.2016.02.023","article-title":"Exercise restrictions for patients with inherited cardiac conditions: current guidelines, challenges and limitations","volume":"209","author":"Hammond-Haley","year":"2016","journal-title":"Int J Cardiol"},{"issue":"22","key":"10.1016\/j.jacep.2025.03.013_bib20","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2025.03.013_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacep.2021.02.013","article-title":"Burst exercise testing can unmask arrhythmias in patients with incompletely penetrant catecholaminergic polymorphic ventricular tachycardia","volume":"7","author":"Roston","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.jacep.2025.03.013_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1012690205052160","article-title":"High school athletic participation and adolescent suicide: a nationwide US study","volume":"40","author":"Sabo","year":"2005","journal-title":"Int Rev Sociol Sport"},{"key":"10.1016\/j.jacep.2025.03.013_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psychres.2016.04.054","article-title":"Exercise improves physical and psychological quality of life in people with depression: a meta-analysis including the evaluation of control group response","volume":"241","author":"Schuch","year":"2016","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.jacep.2025.03.013_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mayocp.2016.08.013","article-title":"The prospective association of organized sports participation with cardiovascular disease risk in children (the CHAMPS Study\u2013DK)","volume":"92","author":"Hebert","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.jacep.2025.03.013_bib25","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.amjcard.2012.12.018","article-title":"Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy","volume":"111","author":"Reineck","year":"2013","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jacep.2025.03.013_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000484","article-title":"Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers","volume":"3","author":"Sweeting","year":"2016","journal-title":"Open Heart"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X25001720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X25001720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:16:45Z","timestamp":1785550605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X25001720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2405500X25001720"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2025.03.013","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and Burdens to Return-to-Play for Phenotype Negative Athletes With a Genetic Heart Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2025.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}